Related Experiment Video
Updated: Aug 9, 2026
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
Published on: September 10, 2014
[Establishment of a cisplatin-multidrug resistance cell line of human osteosarcoma]
Wen-Tao Zhang1, Chong-Qi Tu, Yang Liu
1Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu 610041, China.
Objective:
To establish a multidrug resistance cell line of human osteosarcoma from the MG63 cell line and to test its attributes.
Methods:
The human osteosarcoma MG63 cells were exposed to high and gradually increased dose of cisplatin for 186 days to introduce its multidrug resistance (MG63/R). The sensitivity of the multidrug resistance was measured by MTT assay. The morphology and ultramicrostructure of the cells were observed using optical microscopy and transmission electron microscopy. The proliferation ability of the cells was measured by growth curve and colony-forming assay. The cell cycle and apoptosis and the expression of P-pg, bcl-2, P53 in the MG63 and MG63/R cell lines were analyzed by flow cytometry.
Results:
The resistance index of the MG63/R cells to cisplatin was 83.557 +/- 4.841. The cells also had resistance to doxorubicin, vincristin, methotrexate and cyclophosphamide. Disordered structure of the MG63/R cells was observed through microscopy. The cells appeared in triangle, polygon and polynucleation. The increase of granular endoplasmic reticulums and apophyses was observed through transmission electron microscopy. The proliferation ability of MG63/R increased significantly, with a low apoptosis index. Compared to the MG63, the expressions of P-pg and bcl-2 in the MG63/ R increased while the expression of P53 decreased.
Conclusion:
A multidrug resistance cell line (MG63/R) of human osteosarcoma is established, which will benefit to further studies as a new experimental model.
